Australia starts IVDs regulatory framework impact study
This article was originally published in Clinica
Executive Summary
The Australian Therapeutic Goods Administration is in the process of reviewing feedback from a recent five-week consultation on the new regulatory framework for in vitro diagnostics (IVDs).